LAG3 and cancer: First, inhibitory signaling via LAG‐3 is transmitted by its cytoplasmic KIEELE domain when the receptor binds with high affinity to MHC class II,161 highlighting the potential for both tumor‐associated APC and MHC class II‐expressing cancer cells to suppress T cell function via this pathway.